Vanguard Group Inc Scopus Bio Pharma Inc. Transaction History

Vanguard Group Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.23 - $0.45 $12,569 - $24,592	-54,649 Closed	0 $0
Q2 2022 Aug 12, 2022	SELL	$0.36 - $0.74 $111,525 - $229,246	-309,792 Reduced 85.0%	54,649 $24,000
Q1 2022 May 13, 2022	BUY	$0.6 - $1.7 $840 - $2,380	1,400 Added 0.39%	364,441 $251,000
Q4 2021 Feb 14, 2022	BUY	$1.63 - $4.28 $591,756 - $1.55 Million	363,041 New	363,041 $594,000

100

Ticker SCPS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,094,300
Description
Scopus BioPharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics targeting serious diseases. The company lead development programs are immuno-oncology gene therapy for the treatment of various cancers. It offers Duet Platform, a CpG signal transducer and activator of transcription 3 (STAT3) i...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.